| scholarly article | Q13442814 |
| P50 | author | Fadlo R Khuri | Q86913758 |
| P2093 | author name string | James R Fuchs | |
| Dong M Shin | |||
| Yuan Liu | |||
| Dongsheng Wang | |||
| Zhuo Georgia Chen | |||
| Gabriel Sica | |||
| A R M Ruhul Amin | |||
| Mohammad Aminur Rahman | |||
| Abu Syed Md Anisuzzaman | |||
| Selwyn Hurwitz | |||
| Abedul Haque | |||
| P2860 | cites work | Perspectives on new synthetic curcumin analogs and their potential anticancer properties | Q26851248 |
| Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity | Q26992272 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Comprehensive genomic characterization of head and neck squamous cell carcinomas | Q28256121 | ||
| Bioavailability of curcumin: problems and promises | Q28257125 | ||
| Good cop, bad cop: the different faces of NF-kappaB | Q28291669 | ||
| PI3K and cancer: lessons, challenges and opportunities | Q30080017 | ||
| Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells | Q30493841 | ||
| New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells | Q33424093 | ||
| Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells | Q33792279 | ||
| Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo | Q33914440 | ||
| Cancer prevention with natural compounds | Q34131211 | ||
| Lung cancer chemoprevention: an integrated approach. | Q34372119 | ||
| The multifaceted role of curcumin in cancer prevention and treatment. | Q34667865 | ||
| BCL-2 family antagonists for cancer therapy | Q34891196 | ||
| Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs). | Q35034180 | ||
| Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice | Q36011080 | ||
| New perspectives of curcumin in cancer prevention. | Q36957733 | ||
| Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts | Q37073686 | ||
| Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice | Q37138897 | ||
| Perspectives for cancer prevention with natural compounds | Q37212228 | ||
| Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics | Q37431491 | ||
| The diverse and complex roles of NF-κB subunits in cancer | Q37976939 | ||
| Development of PI3K inhibitors: lessons learned from early clinical trials | Q38080710 | ||
| Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. | Q38172752 | ||
| STAT3 Target Genes Relevant to Human Cancers | Q38205362 | ||
| FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway | Q38881727 | ||
| Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts. | Q39015637 | ||
| RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy | Q39146064 | ||
| PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells | Q39672342 | ||
| New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells | Q39855578 | ||
| Structure-activity relationship studies of curcumin analogues. | Q39878958 | ||
| Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity | Q40002508 | ||
| The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity | Q40121664 | ||
| p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells | Q40274693 | ||
| Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. | Q40959114 | ||
| Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck | Q41140197 | ||
| New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells. | Q45950906 | ||
| Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. | Q53569563 | ||
| PI3K signalling: the path to discovery and understanding. | Q54527804 | ||
| Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS | Q80075359 | ||
| Recent advances in head and neck cancer | Q81950649 | ||
| Apoptosis: a clinical perspective | Q82880941 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 63-73 | |
| P577 | publication date | 2015-10-28 | |
| P1433 | published in | Cancer Prevention Research | Q2665103 |
| P1476 | title | Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers | |
| P478 | volume | 9 |
| Q38843114 | In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review | cites work | P2860 |
Search more.